Track GSK and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
6 tracked superinvestors reported holding GSK in Q2 2026, worth $2.55B in aggregate.
Reported Holders
6
Combined Value
$2.55B
Buying : Selling
0 : 0
| Superinvestor | % of Portfolio | Value | Shares | Change |
|---|---|---|---|---|
Hillman Capital Management filed 2026-08-14 | 3.51% | $4.84M | 92.38K | First tracked quarter |
Dodge & Cox Funds filed 2026-08-13 | 1.32% | $2.53B | 48.20M | First tracked quarter |
Kahn Brothers Group filed 2026-08-17 | 1.31% | $8.31M | 158.44K | First tracked quarter |
Tweedy, Browne filed 2026-08-07 | 0.32% | $4.27M | 81.53K | First tracked quarter |
Sarah Ketterer Causeway Capital · filed 2026-08-13 | 0.00% | $375.47K | 7.16K | First tracked quarter |
Richard Pzena Pzena Investment Management · filed 2026-08-07 | 0.00% | $1.28M | 24.51K | First tracked quarter |